✦ LIBER ✦

Antihypertensive effect of ragaglitazar: A novel PPARα and γ dual activator

✍ Scribed by Prem K. Mamnoor; Pragathi Hegde; Srinivas R. Datla; Ravi K.B. Damarla; Ramanujam Rajagopalan; Ranjan Chakrabarti

Book ID: 117992729
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 230 KB
Volume: 54
Category: Article
ISSN: 1043-6618
DOI: 10.1016/j.phrs.2006.03.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical pharmacokinetics and intersp

Preclinical pharmacokinetics and interspecies scaling of ragaglitazar, a novel biliary excreted PPAR dual activator

✍ Venkata V. Pavankuamr; C. A. Vinu; Ramesh Mullangi; Nuggehally R. Srinivas 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 835 KB

Intravenous pharmacokinetics, oral bioav

Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats

✍ Kota Jagannath; Madhusudana Rao Chaluvadi; Ramesh Mullangi; N.V.S. Rao Mamidi; N 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

[14C] and [3H]-labelling of Ragaglitazar

[14C] and [3H]-labelling of Ragaglitazar: A dual acting PPARα and PPARγ agonist with hypolipidemic and anti-diabetic activity

✍ Jesper B. Kristensen; Steen K. Johansen; Jacob S. Valsborg; Lars Martiny; Christ 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB

## Abstract Currently, Ragaglitazar is being developed as a drug for the treatment of hyperglycaemia and hyperlipidemia in patients with type 2 diabetes. Here, we report the labelling of Ragaglitazar with carbon‐14 and tritium for in vivo and in vitro investigations. Two different carbon‐14 labelle

Design and synthesis of novel PPARα/γ/δ

Design and synthesis of novel PPARα/γ/δ triple activators using a known PPARα/γ dual activator as structural template

✍ John P Mogensen; Lone Jeppesen; Paul S Bury; Ingrid Pettersson; Jan Fleckner; Ja 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Design and Synthesis of Novel PPARα/γ/δ

Design and Synthesis of Novel PPARα/γ/δ Triple Activators (IX) Using a Known PPARα/γ Dual Activator as Structural Template.

✍ John P. Mogensen; et al. et al. 📂 Article 📅 2003 🏛 John Wiley and Sons ⚖ 161 KB 👁 1 views

Ragaglitazar: a novel PPARα & PPARγ agon

Ragaglitazar: a novel PPARα & PPARγ agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models

✍ Ranjan Chakrabarti; Reeba K Vikramadithyan; Parimal Misra; Jagadheshan Hiriyan; 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 234 KB